Catalyst Funds Management Pty Ltd Has $234,000 Holdings in Azenta, Inc. (NASDAQ:AZTA)

Catalyst Funds Management Pty Ltd boosted its holdings in Azenta, Inc. (NASDAQ:AZTA) by 123.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,684 shares of the company’s stock after acquiring an additional 2,584 shares during the period. Catalyst Funds Management Pty Ltd’s holdings in Azenta were worth $234,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in AZTA. State Street Corp increased its position in Azenta by 0.4% during the 3rd quarter. State Street Corp now owns 1,686,993 shares of the company’s stock worth $81,718,000 after buying an additional 6,398 shares during the period. Conestoga Capital Advisors LLC boosted its stake in Azenta by 65.0% in the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company’s stock valued at $78,894,000 after buying an additional 621,830 shares in the last quarter. Allspring Global Investments Holdings LLC boosted its stake in Azenta by 1.4% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company’s stock valued at $65,922,000 after buying an additional 18,529 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in Azenta by 11.6% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 461,603 shares of the company’s stock valued at $23,080,000 after buying an additional 48,064 shares in the last quarter. Finally, Systematic Financial Management LP boosted its stake in Azenta by 8.7% in the third quarter. Systematic Financial Management LP now owns 434,597 shares of the company’s stock valued at $21,052,000 after buying an additional 34,849 shares in the last quarter. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Up 0.7 %

Shares of NASDAQ:AZTA opened at $36.80 on Monday. The stock has a market cap of $1.68 billion, a price-to-earnings ratio of -12.35 and a beta of 1.52. Azenta, Inc. has a 12-month low of $35.90 and a 12-month high of $63.58. The business’s 50 day moving average is $48.16 and its 200 day moving average is $47.03.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. As a group, equities research analysts expect that Azenta, Inc. will post 0.53 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on AZTA. Needham & Company LLC lifted their price target on Azenta from $55.00 to $59.00 and gave the company a “buy” rating in a research note on Thursday, February 6th. Stephens reiterated an “overweight” rating and issued a $60.00 target price on shares of Azenta in a report on Thursday, January 2nd. Evercore ISI lifted their target price on Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a report on Thursday, February 6th. Finally, TD Cowen upgraded Azenta to a “hold” rating in a report on Thursday, February 27th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $58.75.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.